News

20 Jun 2022

Scott Schliebner joins TFS HealthScience to further grow the company offering.

Scott Schliebner has recently joined TFS as Senior Vice President, Clinical Development Services. Based in the US, Scott brings more than 25 years of clinical drug develo...

29 Mar 2022

TFS HealthScience grows in the UK with a new office in central London

We are excited to announce that we are strengthening our presence with the brand-new office in central London, in addition to the Uxbridge location. T...

23 Mar 2022

TFS HealthScience Appoints Head of CDS Sales

TFS HealthScience is excited to announce the appointment of Julia Day as Executive Director and Global Head of Business Development for Clinical Devel...

11 Mar 2022

TFS HealthScience expands its operations in the US with a new headquarter office in RTP

Strategic growth in the region brings TFS, a leading mid-size global CRO, to Research Triangle Park (RTP) to support an increasing demand for tailored...

24 Jan 2022

TFS HealthScience appoints Chief People Officer

TFS HealthScience, a global mid-size CRO, announced that Eva Brike has joined the company as Chief People Officer. Eva will lead all areas of human re...

07 Jan 2022

TFS HealthScience appoints new CFO

TFS HealthScience has announced the appointment of Jesper Hjort as Chief Financial Officer. Joining from FLSmidth, a listed engineering company, Jespe...

27 Jul 2021

TFS HealthScience has been accredited in Medidata Rave RTSM to conduct randomization and drug trial supply management services

This accreditation enables TFS to address complex requirements characteristic of the current clinical research environment. Flexible approach and quic...